Ligand, Spectrum sign Captisol-enabled Melphalan licensing, supply deal
The contract will focus on the development and commercialization of Ligand’s Captisol-enabled, propylene glycol-free (PG-free) melphalan. According to the agreement, Ligand will earn license fee and is eligible